InvestSMART

MGC Pharmaceuticals Ltd (ASX: MXC) - Announcements

Current share price for MXC : $0.420 0.01 (2.44%)+

ASX company news and announcements for MGC Pharmaceuticals Ltd (MXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MGC Pharmaceuticals Ltd (MXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MGC Pharmaceuticals Ltd (MXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MGC Pharmaceuticals Ltd (MXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Application for quotation of securities - MXC 7 Oct 2021 4:01PM $0.059 $0.420 risen by 611.86%
$18 AMC INC. PLACES US$3M CIMETRA PURCHASE ORDER 7 Oct 2021 9:30AM $0.058 $0.420 risen by 624.14%
$18 Company Presentation 6 Oct 2021 8:25AM $0.057 $0.420 risen by 636.84%
$18 Change of Director's Interest Notice - Appendix 3Y 4 Oct 2021 3:18PM $0.059 $0.420 risen by 611.86%
$18 Appendix 4G and Corporate Governance Statement 30 Sep 2021 4:19PM $0.061 $0.420 risen by 588.52%
$18 Full Year Statutory Accounts 30 Sep 2021 4:13PM $0.061 $0.420 risen by 588.52%
$18 FIRST ORDER RECEIVED UNDER US SUPPLY AGREEMENT 30 Sep 2021 8:10AM $0.058 $0.420 risen by 624.14%
$18 s708A(5)(e) Cleansing Notice 22 Sep 2021 3:47PM $0.059 $0.420 risen by 611.86%
$18 Application for quotation of securities - MXC 22 Sep 2021 3:44PM $0.059 $0.420 risen by 611.86%
$18 s708A(5)(e) Cleansing Notice 20 Sep 2021 4:29PM $0.060 $0.420 risen by 600%
$18 Application for quotation of securities - MXC 20 Sep 2021 4:18PM $0.060 $0.420 risen by 600%
$18 Application for quotation of securities - MXC 20 Sep 2021 4:12PM $0.060 $0.420 risen by 600%
$18 ARTEMIC EU SALE APPROVAL AND CLINICAL TRIAL UPDATE 16 Sep 2021 9:38AM $0.062 $0.420 risen by 577.42%
$18 UK IMPORT PERMIT GRANTED FOR CANNEPIL 14 Sep 2021 8:16AM $0.060 $0.420 risen by 600%
$18 Update - Notification of cessation of securities - MXC 10 Sep 2021 6:31PM $0.058 $0.420 risen by 624.14%
$18 Update - Application for quotation of securities - MXC 10 Sep 2021 6:11PM $0.058 $0.420 risen by 624.14%
$18 s708(5)(e) Cleansing Notice 9 Sep 2021 6:39PM $0.060 $0.420 risen by 600%
$18 Appendix 3Y x 6 9 Sep 2021 6:26PM $0.060 $0.420 risen by 600%
$18 Notification regarding unquoted securities - MXC 9 Sep 2021 6:23PM $0.060 $0.420 risen by 600%
$18 Notification of cessation of securities - MXC 9 Sep 2021 6:23PM $0.060 $0.420 risen by 600%
$18 Application for quotation of securities - MXC 9 Sep 2021 6:22PM $0.060 $0.420 risen by 600%
$18 CIMETRA IMPORT APPROVAL GRANTED FOR INDIA 3 Sep 2021 9:43AM $0.047 $0.420 risen by 793.62%
$18 Preliminary Final Report 1 Sep 2021 8:14AM $0.048 $0.420 risen by 775%
$18 Proposed issue of securities - MXC 30 Aug 2021 5:43PM $0.048 $0.420 risen by 775%
$18 Information on expiring options 27 Aug 2021 5:03PM $0.056 $0.420 risen by 650%

276 - 300 of 818 results

Page 12 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.